VCU Stravitz-Sanyal Institute for Liver Disease(@VCU_Liver) 's Twitter Profileg
VCU Stravitz-Sanyal Institute for Liver Disease

@VCU_Liver

The Stravitz-Sanyal Institute for Liver Disease and Metabolic Health at VCU is revolutionizing global health through innovative liver research. 804-828-5066.

ID:1646582754597896209

linkhttps://liverinstitute.medschool.vcu.edu/ calendar_today13-04-2023 18:35:16

723 Tweets

381 Followers

424 Following

CDC Hepatitis(@cdchep) 's Twitter Profile Photo

It’s ! Make sure your community health partners have the most up-to-date recommendations on screening and vaccination: bit.ly/3svyHyV.

It’s #HepatitisAwarenessMonth! Make sure your community health partners have the most up-to-date recommendations on #HepatitisC screening and #HepatitisB vaccination: bit.ly/3svyHyV.
account_circle
VCU Stravitz-Sanyal Institute for Liver Disease(@VCU_Liver) 's Twitter Profile Photo

If you have , why not skip the grilled hamburger 🍔 this weekend? Do your some good. Chow down instead on a vegan or bean burger. Find out why this is a recipe for health success: bit.ly/4dp7fM0 twitter Jasmohan Bajaj

If you have #cirrhosis, why not skip the grilled hamburger 🍔 this #MemorialDay weekend? Do your #liver some good. Chow down instead on a vegan or bean burger. Find out why this is a recipe for health success: bit.ly/4dp7fM0 #livertwitter @JasmohanBajaj
account_circle
VCU Stravitz-Sanyal Institute for Liver Disease(@VCU_Liver) 's Twitter Profile Photo

New study led by VCU Massey Comprehensive Cancer Center's Devanand Sarkar determined that a specific mutation exhibits zone-specific differential gene expression, which might contribute to the onset of HCC. Via Journal of Biological Chemistry bit.ly/4bOuGMV

New study led by @VCUMassey's Devanand Sarkar determined that a specific mutation exhibits zone-specific differential gene expression, which might contribute to the onset of HCC. Via @jbiolchem #livertwitter bit.ly/4bOuGMV
account_circle
Rohit Loomba(@DrLoomba) 's Twitter Profile Photo

This is an important paper please take a quick read you will learn a lot regarding screen failure rates in Nash trials and what to do about it AASLD Digestive Disease Week EASLnews

account_circle
VCU Stravitz-Sanyal Institute for Liver Disease(@VCU_Liver) 's Twitter Profile Photo

From our director, @arunjsanyalVCU. At : REGENERATE: Final Results for Obeticholic Acid for Pre-Cirrhotic Fibrosis Due to bit.ly/3yCcuYw via @hcplive

From our director, @arunjsanyalVCU. At #DDW2024: REGENERATE: Final Results for Obeticholic Acid for Pre-Cirrhotic Fibrosis Due to #NASH bit.ly/3yCcuYw via @hcplive #livertwitter #MASH
account_circle
VCU Stravitz-Sanyal Institute for Liver Disease(@VCU_Liver) 's Twitter Profile Photo

Now in J of Viral Hepatitis: Test characteristics for combining non-invasive fibrosis staging modalities in individuals with bit.ly/3SzYCVj our CCO Richard Sterling twitter

account_circle
STAT(@statnews) 's Twitter Profile Photo

A new study suggests that gabapentin could provide greater benefit than FDA-approved drugs for patients with alcohol-associated liver disease. trib.al/sjodtBq

account_circle
VCU Stravitz-Sanyal Institute for Liver Disease(@VCU_Liver) 's Twitter Profile Photo

Our CCO, Richard Sterling (rear, right), is having way too much fun at , with physicians Guadalupe Garcia-Tsao (front, left), Elizabeth Verna (front, right), Cynthia Levy (rear, left), and Sumeet Asrani, (rear, middle). A fine demonstration of collegiality.

Our CCO, @RichSterlingMD (rear, right), is having way too much fun at #DDW2024, with physicians Guadalupe Garcia-Tsao (front, left), Elizabeth Verna (front, right), Cynthia Levy (rear, left), and Sumeet Asrani, (rear, middle). A fine demonstration of collegiality. #livertwitter
account_circle
VCU Stravitz-Sanyal Institute for Liver Disease(@VCU_Liver) 's Twitter Profile Photo

Development of Fibro-PeN, a clinical prediction model for moderate-to-severe fibrosis in children with NAFLD. Thanks to a great group of leaders and NASH CRN colleagues, including our @Saulkarpen. bit.ly/3KazG2L

account_circle
Naim Alkhouri(@AlkhouriNaim) 's Twitter Profile Photo

The results of the interim analysis of Survodutide for MASH w fibrosis were presented today at Digestive Disease Week . 🔑 findings: 1. Up to 90% decreased liver fat by > 30%. 2. Great reduction in ALT/ AST. Great reduction in ELF. The future is bright Mazen Noureddin, MD, MHSc VCU Stravitz-Sanyal Institute for Liver Disease Ramy Younes, MD, PhD g

The results of the interim analysis of Survodutide for MASH w fibrosis were presented today at @DDWMeeting . 🔑 findings: 1. Up to 90% decreased liver fat by > 30%. 2. Great reduction in ALT/ AST. Great reduction in ELF. The future is bright @NoureddinMD @VCU_Liver @RamyYounes9 g
account_circle
Digestive Disease Week(@DDWMeeting) 's Twitter Profile Photo

.Richard Sterling shares 5 things physicians should keep in mind when reviewing @AASLDtweet’s new non-invasive liver disease assessment practice guidelines ow.ly/SwyQ50RLEla

.@RichSterlingMD shares 5 things physicians should keep in mind when reviewing @AASLDtweet’s new non-invasive liver disease assessment practice guidelines #DDW2024 #NILDA ow.ly/SwyQ50RLEla
account_circle
VCU Stravitz-Sanyal Institute for Liver Disease(@VCU_Liver) 's Twitter Profile Photo

May is Hepatitis Awareness Month in the U.S., and Sunday, May 19, is Hepatitis Testing Day. If left untreated, hepatitis can turn into cancer. Get tested. Learn about treatments, prevention and management of the virus. twitter

May is Hepatitis Awareness Month in the U.S., and Sunday, May 19, is Hepatitis Testing Day. If left untreated, hepatitis can turn into #liver cancer. Get tested. Learn about treatments, prevention and management of the virus. #HepCantWait #LiverHealthisPublicHealth #livertwitter
account_circle